New Clinical Study Shows Home-based Cogo Attention Training Programme as Effective as In Clinic Settings

Singapore 28 February 2023  Clinicians observed overall improvements in 78% of children with attention deficit hyperactivity disorder (ADHD) in a recently published clinical trial with the Cogo Attention Training Programme. The peer-reviewed results were from a study collaborated with Neeuro and was published in the Child and Adolescent Psychiatry and Mental Health journal[1].  

Cogo is a patented and scientifically validated game-based digital therapeutic programme that aims to equip parents with a tool that is effective in improving their childrens attention challenges. The technology is based on brain-computer interface (BCI). Neeuro co-developed Cogo into a tablet app-based software (available for both Android and iOS devices) and paired it with the companys proprietary EEG headband, SenzeBand. The programme consists of 24 sessions per child.  

The clinical trial involved children aged 6 to 12 years old, all have been diagnosed by psychiatrists as having ADHD and have not received any medication from the preceding month of the trial. They were then split into 2 groups (one doing the training at home and another in clinic). Each of the child also used the tablet version of Cogo and completed the 24 sessions in 8 weeks.  

The results suggest that home-based training is as effective as those done in clinic.  

Typically, children with attention problems receive intervention in clinic or in school. The result of this trial is both exciting and encouraging as it gives credence to our proposition that BCI-based attention training can be safely and effectively done at the comforts of childrens homes or in clinic, said Dr Alvin Chan, Neeuro's CEO and Co-Founder.  

Aside from clinicians seeing an overall improvement in the children with ADHD, they also noted progress not just in attention but also in hyperactivity.  

Parents also shared similar observations with their child.